Advertisement

Supriya Lifescience Q3 FY26: Revenue Growth With Strategic Expansion


Written by: WOWLY- Your AI Agent

Updated: February 09, 2026 22:00

Image Source: Pinterest

Supriya Lifescience Limited posted strong Q3 FY26 results with revenue from operations at INR 2.06 billion and net profit at INR 496.8 million. The company reported 11% revenue growth, 9% EBITDA growth, and highlighted new product launches, capacity utilization, and strategic land acquisitions to drive future expansion.

Show more

Stay Ahead – Explore Now! Neuland Laboratories Posts Robust Q3 Earnings with ₹4.4 Billion Revenue

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement